Cargando…
Downregulation of PGM5 expression correlates with tumor progression and poor prognosis in human prostate cancer
Prostate cancer (PCa) is the most common malignancy in men in developed countries. Prostate-specific antigen (PSA) remains the most widely used serum marker for prostate cancer. Here, we reported that the expression of phosphoglucomutase-like protein 5 (PGM5) is significantly lower in prostate cance...
Autores principales: | Sun, Jian, Wang, Fei, Zhou, Huihui, Zhao, Chunchun, Li, Kai, Fan, Caibin, Wang, Jianqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276915/ https://www.ncbi.nlm.nih.gov/pubmed/35819729 http://dx.doi.org/10.1007/s12672-022-00525-x |
Ejemplares similares
-
HNF1B inhibits cell proliferation via repression of SMAD6 expression in prostate cancer
por: Lu, Wei, et al.
Publicado: (2020) -
Significance of PTEN Mutation in Cellular Process, Prognosis, and Drug Selection in Clear Cell Renal Cell Carcinoma
por: Fan, Caibin, et al.
Publicado: (2019) -
ZBTB38 suppresses prostate cancer cell proliferation and migration via directly promoting DKK1 expression
por: Ding, Guanxiong, et al.
Publicado: (2021) -
Significance of TP53 mutation in bladder cancer disease progression and drug selection
por: Wu, Guang, et al.
Publicado: (2019) -
Meta-analysis of the effect of PGM on survival prognosis of tumor patients
por: Zheng, Zhewen, et al.
Publicado: (2022)